1. Home
  2. NKTR vs CNL Comparison

NKTR vs CNL Comparison

Compare NKTR & CNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • CNL
  • Stock Information
  • Founded
  • NKTR 1990
  • CNL 2018
  • Country
  • NKTR United States
  • CNL Canada
  • Employees
  • NKTR N/A
  • CNL N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • CNL
  • Sector
  • NKTR Health Care
  • CNL
  • Exchange
  • NKTR Nasdaq
  • CNL NYSE
  • Market Cap
  • NKTR 238.7M
  • CNL 229.8M
  • IPO Year
  • NKTR 1994
  • CNL N/A
  • Fundamental
  • Price
  • NKTR $1.32
  • CNL $3.20
  • Analyst Decision
  • NKTR Buy
  • CNL
  • Analyst Count
  • NKTR 4
  • CNL 0
  • Target Price
  • NKTR $2.50
  • CNL N/A
  • AVG Volume (30 Days)
  • NKTR 988.9K
  • CNL 7.0K
  • Earning Date
  • NKTR 11-05-2024
  • CNL 01-01-0001
  • Dividend Yield
  • NKTR N/A
  • CNL N/A
  • EPS Growth
  • NKTR N/A
  • CNL N/A
  • EPS
  • NKTR N/A
  • CNL N/A
  • Revenue
  • NKTR $93,157,000.00
  • CNL N/A
  • Revenue This Year
  • NKTR N/A
  • CNL N/A
  • Revenue Next Year
  • NKTR N/A
  • CNL N/A
  • P/E Ratio
  • NKTR N/A
  • CNL N/A
  • Revenue Growth
  • NKTR 6.17
  • CNL N/A
  • 52 Week Low
  • NKTR $0.41
  • CNL $2.43
  • 52 Week High
  • NKTR $1.93
  • CNL $3.63
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 56.07
  • CNL N/A
  • Support Level
  • NKTR $1.11
  • CNL N/A
  • Resistance Level
  • NKTR $1.39
  • CNL N/A
  • Average True Range (ATR)
  • NKTR 0.09
  • CNL 0.00
  • MACD
  • NKTR 0.01
  • CNL 0.00
  • Stochastic Oscillator
  • NKTR 75.00
  • CNL 0.00

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About CNL COLLECTIVE MINING LTD

Collective Mining Ltd is an exploration and development company focused on identifying and exploring prospective mineral projects in South America. The company currently has 100% interest in two projects located in Colombia, namely, Guayabales and San Antonio. The company is responsible for discovering, permitting, and constructing the gold mine in Colombia. The company is rapidly advancing exploration on large-scale copper-gold-molybdenum porphyry targets in the mining-friendly department of Caldas in Colombia. Drilling is underway at the Guayabales project which is strategically located contiguous to the Marmato deposit, with initial assay results ongoing.

Share on Social Networks: